GeneDx Holdings
86 hedge funds and large institutions have $37.3M invested in GeneDx Holdings in 2022 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 25 increasing their positions, 27 reducing their positions, and 23 closing their positions.
9,536% more call options, than puts
Call options by funds: $1.06M | Put options by funds: $11K
0.15% less ownership
Funds ownership: 1.26% → 1.11% (-0.15%)
7% less repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 27
12% less funds holding
Funds holding: 98 → 86 (-12)
52% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 23
73% less capital invested
Capital invested by funds: $138M → $37.3M (-$101M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$8.12M |
| 2 |
Renaissance Technologies
New York
|
+$1.48M |
| 3 |
NM
Newtyn Management
New York
|
+$734K |
| 4 |
TMC
Trellus Management Company
Delray Beach,
Florida
|
+$439K |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$428K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TP
Third Point
New York
|
-$4.87M |
| 2 |
DM
Deerfield Management
New York
|
-$4.62M |
| 3 |
CM
Corvex Management
New York
|
-$4.53M |
| 4 |
PA
Perceptive Advisors
New York
|
-$4.39M |
| 5 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
-$3.95M |
WGS Hedge Fund Activity: Q4 2022 in Review
86 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in GeneDx Holdings (WGS) for Q4 2022, worth a combined $37.3M — down 73% from $138M a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of WGS and 11 opened new positions — a net loss of 12 holders — while 27 trimmed existing stakes and 25 added.
The largest buyer was Goldman Sachs, adding an estimated $8.12M. The largest seller was Third Point, exiting entirely with an estimated $4.87M sold.
- 86 institutional investors held GeneDx Holdings (WGS) as of Q4 2022, down from 98 in Q3 2022.
- Funds reported $37.3M of GeneDx Holdings stock for Q4 2022, down 73% quarter-over-quarter.
- 11 funds opened new GeneDx Holdings positions in Q4 2022 and 23 closed out, a net change of -12 holders.
- The largest GeneDx Holdings buyer in Q4 2022 was Goldman Sachs, an estimated $8.12M added.
- The largest GeneDx Holdings seller in Q4 2022 was Third Point, an estimated $4.87M sold.
Based on aggregated 13F filings for Q4 2022.